Ozempic Cost: What You Pay and How Insurance Changes It

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub, your resource on GLP-1 therapy, weight management protocols, and the genetics behind every metabolic decision. Browse all Peptides & GLP-1 education

Few GLP-1 questions come up as often as what Ozempic actually costs. The honest answer is that the number you pay is assembled from several moving parts: your plan, the indication on your prescription, savings-card eligibility, and whether a compounded option is on the table. This article breaks those parts down as of April 2026, reported as published rather than as a guarantee.

What drives your Ozempic cost

Ozempic list price is approximately $968 to $1,029 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). That figure is only the starting point. What lands on your receipt is shaped by insurance coverage, the FDA-approved indication the prescription is written for, any manufacturer savings program, and the pharmacy filling it. Two patients on the same medication can pay very different amounts once those variables interact, which is why a single quoted figure rarely tells the whole story. List price is rarely what an insured patient actually pays.

Coverage, formularies, and prior authorization

Whether a plan covers Ozempic turns on the FDA indication and the plan's own formulary. Many commercial plans cover semaglutide for type 2 diabetes, while coverage for chronic weight management is more variable and often gated behind prior authorization or BMI-based criteria. Because formulary rules differ plan to plan, confirm your specific coverage directly with your insurer as of April 2026. The indication on the prescription is often the single biggest factor, since a diabetes indication and a weight-management indication can be treated very differently by the same plan.

Manufacturer and pharmacy savings routes

Novo Nordisk publishes a manufacturer savings card that can meaningfully lower monthly out-of-pocket cost for eligible commercially-insured patients. Separately, independent pharmacy discount platforms such as GoodRx and SingleCare publish coupon prices that vary by pharmacy. Both eligibility rules and savings amounts change over time, so verify current terms on the manufacturer site or with your pharmacy at the time of fill.

The compounded-pharmacy option after the shortage

From 2022 to 2024 the FDA listed semaglutide on its drug shortage list, opening a pathway for licensed 503A compounding pharmacies to prepare semaglutide formulations. The FDA resolved that shortage in 2024, narrowing but not eliminating the pathway. Legitimate compounded protocols, prescribed by a licensed clinician through a state-licensed compounding pharmacy, remain a real option, though pricing and access vary widely.

Where PlexusDx protocols fit on cost

PlexusDx offers clinician-supervised compounded GLP-1 protocols inside its Weight Management Protocols, including Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, Tirzepatide Oral, Microdose GLP-1, and GLP-Squared. See the relevant product page for current pricing as of April 2026.

Upstream of any protocol decision, the PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, and MC4R that shape baseline GLP-1, appetite-regulation, and energy-balance biology. That genetic context is the test before you invest framing PlexusDx brings to every protocol conversation.

Related reading on PlexusDx: Ozempic Before and After, Ozempic Pill, Ozempic for Sale, Victoza vs Ozempic.

Disclaimer: This article is educational. PlexusDx offers semaglutide through its Weight Management Protocols, and this article covers the mechanism, evidence, and genetic context that inform any decision to use it. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Learn more about the PlexusDx Semaglutide protocol or the oral semaglutide protocol inside the Weight Management Protocols collection. To begin upstream with genetic context, take the Precision Peptide Genetic Test first.

Frequently Asked Questions

What is the total monthly cost of Ozempic?

Ozempic list price is approximately $968 to $1,029 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). Your total depends on coverage, the indication on the prescription, savings-card eligibility, and the pharmacy. Confirm the actual out-of-pocket figure with your pharmacy before the fill.

Does the indication on my prescription change the cost?

Yes. Many commercial plans cover semaglutide for type 2 diabetes but treat chronic weight management differently, often requiring prior authorization or BMI-based criteria. Because coverage follows the FDA indication and your plan's formulary, the same medication can cost very different amounts depending on why it was prescribed.

Can compounded semaglutide lower my cost?

It can. Compounded semaglutide from licensed 503A pharmacies has historically been priced below Ozempic list price. The trade-offs are regulatory complexity, variation in prescriber oversight, and the FDA's evolving stance after the 2024 shortage resolution. Discuss suitability with a qualified clinician before choosing this route.

How does the Precision Peptide Genetic Test factor into cost decisions?

It does not predict response or set a price, but it adds upstream context. By analyzing pathway-level variants in FTO, and MC4R that shape baseline GLP-1 biology, it helps frame a more informed protocol conversation before you commit spending to any GLP-1 approach.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.